Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001772792 | SCV001993425 | uncertain significance | not provided | 2021-02-08 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV002477947 | SCV002783737 | uncertain significance | Polycystic kidney disease, adult type | 2022-01-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002540328 | SCV003754760 | uncertain significance | Inborn genetic diseases | 2021-08-02 | criteria provided, single submitter | clinical testing | The c.6403G>A (p.A2135T) alteration is located in exon 15 (coding exon 15) of the PKD1 gene. This alteration results from a G to A substitution at nucleotide position 6403, causing the alanine (A) at amino acid position 2135 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |